Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBP.L Regulatory News (CBP)

  • There is currently no data for CBP

Form 8.3 - Curtis Banks Group plc

30 Mar 2023 15:25

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

 

Millennium International Management LP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Curtis Banks Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

29th March 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

 

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

0.5p ordinary (GB00BW0D4R71)

 

 

 

Interests

 

Short positions

 

Number

 

%

 

Number

 

%

(1) Relevant securities owned and/or controlled:

 

-

 

-

 

-

 

-

(2) Cash-settled derivatives:

 

 

1,508,841

 

2.256%

 

-

 

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

-

 

-

 

-

 

-

 

TOTAL:

 

1,508,841

 

2.256%

 

-

 

-

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

 

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (GBP)

 

 

 

 

(b) Cash-settled derivative transactions

Class of relevant security

 

Product description

e.g. CFD

 

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 

Number of reference securities

 

Price per unit

(GBP)

GB00BW0D4R71

 

Equity Swap

 

Increasing a long position

 

654

 

3.42

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

 

Product description e.g. call option

 

Writing, purchasing, selling, varying etc.

 

Number of securities to which option relates

 

Exercise price per unit

 

Type

e.g. American, European etc.

 

Expiry date

 

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

 

Product description

e.g. call option

 

Exercising/ exercised against

 

Number of securities

 

Exercise price per unit

 

 

 

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

 

Nature of dealing

e.g. subscription, conversion

 

Details

 

Price per unit (if applicable)

 

 

 

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

NONE

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

 

NO

Date of disclosure:

 

30th March 2023

Contact name:

 

Roisin Nagle

 

Telephone number:

 

+44 203 192 8746

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230330005501/en/

Copyright Business Wire 2023

Date   Source Headline
1st Nov 20214:35 pmRNSPrice Monitoring Extension
21st Oct 20214:41 pmRNSHolding(s) in Company
21st Oct 20212:48 pmRNSHolding(s) in Company
20th Oct 20213:08 pmRNSHolding(s) in Company
20th Oct 20217:00 amRNSDirector/PDMR Dealing
11th Oct 20219:38 amRNSDirector/PDMR Dealing
22nd Sep 20211:00 pmRNSDividend Timetable
9th Sep 20217:00 amRNSInterim Results
1st Sep 20214:35 pmRNSTR-1: Notification of major holdings
19th Jul 20217:00 amRNSTrading Update
25th Jun 20213:00 pmRNSHolding(s) in Company
9th Jun 20217:00 amRNSTR1: Notification of Major Holdings
8th Jun 20212:55 pmRNSDirector/PDMR Shareholding
3rd Jun 20212:03 pmRNSDirector/PDMR Shareholding
27th May 20214:40 pmRNSResult of AGM
12th May 20215:11 pmRNSCorrection to Notice of Annual General Meeting
30th Apr 20217:00 amRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20217:00 amRNSDirector/PDMR Shareholding
19th Apr 20214:24 pmRNSDirector/PDMR Shareholding
12th Apr 20215:37 pmRNSDirector/PDMR Shareholding
8th Apr 20215:59 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSFinal Results
17th Mar 20217:00 amRNSUpdate on Timing of Full Year Results Announcement
5th Feb 202110:12 amRNSHolding(s) in Company
19th Jan 20217:00 amRNSAppointment of Non-Executive Director
12th Jan 20217:00 amRNSTrading Update
18th Dec 20207:00 amRNSDirector/PDMR Shareholding
30th Nov 20207:00 amRNSTrading and Operations Update
26th Nov 20204:49 pmRNSHolding(s) in Company
13th Nov 20204:33 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSDirector/PDMR Shareholding
28th Oct 202010:00 amRNSDirector/PDMR Shareholding
6th Oct 20207:00 amRNSCompletion of acquisition of Talbot and Muir
5th Oct 20204:40 pmRNSSecond Price Monitoring Extn
5th Oct 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSLong-Term Incentive Plan
7th Sep 20207:01 amRNSInvestor Presentation
7th Sep 20207:00 amRNSDividend timetable
3rd Sep 20207:00 amRNSInterim Results
25th Aug 20204:41 pmRNSSecond Price Monitoring Extn
25th Aug 20204:36 pmRNSPrice Monitoring Extension
4th Aug 20207:00 amRNSNotice of Results
30th Jul 202012:26 pmRNSHolding(s) in Company
28th Jul 20209:20 amRNSHolding(s) in Company
27th Jul 20206:14 pmRNSHolding(s) in Company
23rd Jul 20202:20 pmRNSResult of placing
23rd Jul 20207:27 amRNSProposed Placing to raise £25m
23rd Jul 20207:25 amRNSAcquisition of Talbot and Muir and Dunstan Thomas
16th Jun 20204:41 pmRNSSecond Price Monitoring Extn
16th Jun 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.